NCT01116648 2026-03-05Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast CancerNational Cancer Institute (NCI)Phase 1/2 Active not recruiting155 enrolled 34 charts